Drug interactions
Belzutifan + Enzalutamide
Severity: Minor
Belzutifan and Enzalutamide: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Belzutifan can induce CYP3A4 and may lower exposure of sensitive CYP3A4 substrates, and enzalutamide is a CYP3A4 substrate but also mixed in effect. The net effect on enzalutamide is uncertain, and both are used in oncology with efficacy implications.
What this interaction means in plain words
Belzutifan and Enzalutamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Belzutifan belongs to Miscellaneous; Enzalutamide belongs to Endocrine.
Why it happens
Belzutifan may induce CYP3A4 and reduce substrate exposure; the net effect on enzalutamide is not well characterized.
What to do
Monitor clinical response and PSA where relevant; no empirical dose change is established.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Belzutifan and Enzalutamide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Enzalutamide
- Doravirine + Enzalutamide Contraindicated
- Elbasvir / grazoprevir + Enzalutamide Contraindicated
- Ensitrelvir + Enzalutamide Contraindicated
- Enzalutamide + Fostemsavir Contraindicated
- Enzalutamide + Isavuconazonium Contraindicated
- Enzalutamide + Lenacapavir Contraindicated
Other interactions of Belzutifan
Frequently asked questions
Can I take Belzutifan with Enzalutamide?
MediHelp rates the interaction as minor. Belzutifan and Enzalutamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Belzutifan can induce CYP3A4 and may lower exposure of sensitive CYP3A4 substrates, and enzalutamide is a CYP3A4 substrate but also mixed in effect. The net effect on enzalutamide is uncertain, and both are used in oncology with efficacy implications.
How serious is the interaction between Belzutifan and Enzalutamide?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response and PSA where relevant; no empirical dose change is established.
What other medicines interact with Enzalutamide?
MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
